SCHEMBL30583785

SCHEMBL30583785

COC(=O)[C@H](C)NP(=O)(Oc1ccc([N+](=O)[O-])cc1)Oc1ccc(Cl)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.39
▸ LMNA P02545 5/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ RORC P51449 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ BTN3A1 O00481 2/20 0.38
▸ ESRRA P11474 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23440681 0.91 ALDH1A1 (0.40) MAPTLMNAKMT2AMEN1RORC
SCHEMBL23440680 0.91 ALDH1A1 (0.40) MAPTLMNAKMT2AMEN1RORC
SCHEMBL30511516 0.89 BTN3A1 (0.38) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL30583787 0.88 GAA (0.42) MAPTLMNAKMT2AMEN1RORC
SCHEMBL30511498 0.86 ALOX5 (0.41) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL19361265 0.85 ALDH1A1 (0.48) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL15343943 0.85 ALDH1A1 (0.48) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL28841738 0.85 ALDH1A1 (0.48) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL15343942 0.85 ALDH1A1 (0.48) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL18742082 0.84 CA1 (0.51) MAPTLMNAKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202850-B2 Cyclobutyl purine derivative or salt thereof FUJIFILM CORPORATION (JP) 2025-01-21 — — US disclosed
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295202-A1 CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF SLC28A1, SLC20A1, SLC29A1 MAPT 4397/4885LMNA 2968/4885KMT2A 4442/4885
US-12202850-B2 Cyclobutyl purine derivative or salt thereof SLC28A1, SLC20A1, SLC29A1 MAPT 4397/4885LMNA 2968/4885KMT2A 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback